ArticleAntimicrobial agents and chemotherapy2008

Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.

Daniel Gonzalez de Requena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.